Mioduchoski, FNP-BC BPC-157 continues to be studied, and long-term human research remains limited
The advance could accelerate drug development by making it easier to design peptide drug candidates likely to have particular effects, such as improving GLP-1-related therapies for weight loss or diabetes, quieting brain signals involved in addiction or helping immune cells fight cancer, rather than generating new candidates first and testing them later to discover what they do
Share this case with your medication safety committee and clinical teams that care for patients in the outpatient, urgent care, and emergency settings
Connect with a provider swiftly via our telehealth platforma process that only requires a smartphone, tablet, or computer
When paired with BPC-157, its anti-inflammatory properties become evident as well